.
MergerLinks Header Logo

New Deal


Announced

Oaktree to invest $150m in Draslovka.

Financials

Edit Data
Transaction Value£114m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Pending

Specialty Chemicals

Acquisition

Friendly

Minority

Cross Border

Czechia

Private Equity

Private

specialty chemicals

Single Bidder

Synopsis

Edit

Oaktree, an investment firm, agreed to invest $150m in Draslovka, a manufacturer of cyanide-based chemical specialties and agricultural chemicals. “We are delighted to enter into the strategic partnership with Oaktree as we look to deliver on our ambitious growth strategy. Oaktree brings significant investment expertise and a broad industry knowledge to Draslovka, and this investment is not only a strong endorsement of the success we have delivered to date but an indication that there is much more to come. We look forward to working alongside Oaktree as we deliver on our ambitious growth targets," Pavel Brůžek, Draslovka CEO

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US